Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers.

Drake RR, Cazare LH, Semmes OJ, Wadsworth JT.

Expert Rev Mol Diagn. 2005 Jan;5(1):93-100. Review.

PMID:
15723595
2.

Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma.

Ohshiro K, Rosenthal DI, Koomen JM, Streckfus CF, Chambers M, Kobayashi R, El-Naggar AK.

Int J Oncol. 2007 Mar;30(3):743-9.

PMID:
17273777
3.

Mass spectrometry-based salivary proteomics for the discovery of head and neck squamous cell carcinoma.

Jarai T, Maasz G, Burian A, Bona A, Jambor E, Gerlinger I, Mark L.

Pathol Oncol Res. 2012 Jul;18(3):623-8. doi: 10.1007/s12253-011-9486-4. Epub 2012 Feb 15.

PMID:
22350791
4.

Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.

Freed GL, Cazares LH, Fichandler CE, Fuller TW, Sawyer CA, Stack BC Jr, Schraff S, Semmes OJ, Wadsworth JT, Drake RR.

Laryngoscope. 2008 Jan;118(1):61-8.

PMID:
18043497
5.

Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer.

Jou YJ, Lin CD, Lai CH, Chen CH, Kao JY, Chen SY, Tsai MH, Huang SH, Lin CW.

Anal Chim Acta. 2010 Nov 29;681(1-2):41-8. doi: 10.1016/j.aca.2010.09.030. Epub 2010 Sep 25.

PMID:
21035601
6.
7.
8.

Salivary proteomics in biomedical research.

Zhang A, Sun H, Wang P, Wang X.

Clin Chim Acta. 2013 Jan 16;415:261-5. doi: 10.1016/j.cca.2012.11.001. Epub 2012 Nov 9. Review.

PMID:
23146870
9.

Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.

Matta A, Ralhan R, DeSouza LV, Siu KW.

Mass Spectrom Rev. 2010 Nov-Dec;29(6):945-61. doi: 10.1002/mas.20296. Review.

PMID:
20945361
10.

Proteomics: clinical applications for head and neck squamous cell carcinoma.

Yarbrough WG, Slebos RJ, Liebler D.

Head Neck. 2006 Jun;28(6):549-58. Review.

PMID:
16475197
11.

Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.

Matta A, DeSouza LV, Shukla NK, Gupta SD, Ralhan R, Siu KW.

J Proteome Res. 2008 May;7(5):2078-87. doi: 10.1021/pr7007797. Epub 2008 Apr 12.

PMID:
18407684
12.

Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome.

Marimuthu A, Chavan S, Sathe G, Sahasrabuddhe NA, Srikanth SM, Renuse S, Ahmad S, Radhakrishnan A, Barbhuiya MA, Kumar RV, Harsha HC, Sidransky D, Califano J, Pandey A, Chatterjee A.

Biochim Biophys Acta. 2013 Nov;1834(11):2308-16. doi: 10.1016/j.bbapap.2013.04.029. Epub 2013 May 7.

PMID:
23665456
13.

Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.

Zhou L, Cheng L, Tao L, Jia X, Lu Y, Liao P.

Acta Otolaryngol. 2006 Aug;126(8):853-60.

PMID:
16846929
14.

Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip technology, two-dimensional gel electrophoresis, tandem mass spectrometry, and immunohistochemistry.

Melle C, Ernst G, Schimmel B, Bleul A, Koscielny S, Wiesner A, Bogumil R, Moller U, Osterloh D, Halbhuber KJ, von Eggeling F.

Mol Cell Proteomics. 2003 Jul;2(7):443-52. Epub 2003 Jun 23.

15.

Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers.

Ralhan R, Masui O, Desouza LV, Matta A, Macha M, Siu KW.

Proteomics. 2011 Jun;11(12):2363-76. doi: 10.1002/pmic.201000186. Epub 2011 May 20.

PMID:
21598386
16.

[Tumor markers and biomarkers in squamous cell cancer of the head and neck].

Lordick F, Krauss J, Jäger D.

HNO. 2008 Sep;56(9):881-5. doi: 10.1007/s00106-008-1762-6. Review. German.

PMID:
18696018
17.

Evolving 'omics' technologies for diagnostics of head and neck cancer.

Nagaraj NS.

Brief Funct Genomic Proteomic. 2009 Jan;8(1):49-59. doi: 10.1093/bfgp/elp004. Epub 2009 Mar 9. Review.

18.

Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry.

Baker H, Patel V, Molinolo AA, Shillitoe EJ, Ensley JF, Yoo GH, Meneses-García A, Myers JN, El-Naggar AK, Gutkind JS, Hancock WS.

Oral Oncol. 2005 Feb;41(2):183-99.

PMID:
15695121
19.

Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.

Roblick UJ, Bader FG, Hammarstedt L, Habermann JK, Hellman U, Becker S, Sundmacker A, Gemoll T, Zimmermann K, Auer G, Munck-Wikland E.

Acta Oncol. 2008;47(8):1493-501. doi: 10.1080/02841860802314696.

PMID:
18759147
20.

Salivary proteomic analysis of diabetic patients for possible oral squamous cell carcinoma biomarkers.

Jancsik VA, Gelencser G, Maasz G, Schmidt J, Molnar GA, Wittmann I, Olasz L, Mark L.

Pathol Oncol Res. 2014 Jul;20(3):591-5. doi: 10.1007/s12253-013-9736-8. Epub 2013 Dec 17.

PMID:
24343817
Items per page

Supplemental Content

Write to the Help Desk